GUANGZHOU, CHINA - Media OutReach Newswire - 27 April 2026 - The China International Exhibition for Metro Transit and CAMET ...
Achieved $18.5 million in first quarter of 2026 net product revenues for IBTROZI® (taletrectinib); majority of the approximately 200 patients started on IBTROZI in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results